Machine learning for COVID-19—asking the right questions

[1]  Matthias Gutberlet,et al.  1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study. , 2016, Journal of the American College of Cardiology.

[2]  A. Nicholson,et al.  An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. , 2014, The Lancet. Respiratory medicine.

[3]  David C. Kale,et al.  Do no harm: a roadmap for responsible machine learning for health care , 2019, Nature Medicine.

[4]  M. Nishimura,et al.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.

[5]  Geraint Rees,et al.  Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.

[6]  Erika Hayasaki,et al.  Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide , 2020, BMJ.

[7]  K. Cao,et al.  Using Artificial Intelligence to Detect COVID-19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy , 2020 .

[8]  Nicola Sverzellati,et al.  Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia , 2020, Radiology.

[9]  D. Murdoch,et al.  Clinical course and mortality risk of severe COVID-19 , 2020, The Lancet.

[10]  Shiqian Ma,et al.  Highly accurate model for prediction of lung nodule malignancy with CT scans , 2018, Scientific Reports.

[11]  K. Cao,et al.  Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT , 2020, Radiology.